CSNpharm
CSNpharm
Brefeldin A inhibits protein translocation from the endoplasmic reticulum (ER) to the Golgi apparatus reversibly, can be used to induce autophagy in mammalian cells.
More Information
Supplier Page
CSNpharm
Brefeldin A inhibits protein translocation from the endoplasmic reticulum (ER) to the Golgi apparatus reversibly, can be used to induce autophagy in mammalian cells.
More Information
Supplier Page
CSNpharm
Brefeldin A inhibits protein translocation from the endoplasmic reticulum (ER) to the Golgi apparatus reversibly, can be used to induce autophagy in mammalian cells.
More Information
Supplier Page
CSNpharm
Brefeldin A inhibits protein translocation from the endoplasmic reticulum (ER) to the Golgi apparatus reversibly, can be used to induce autophagy in mammalian cells.
More Information
Supplier Page
CSNpharm
Brequinar (DUP785) is a potent inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of 5.2 nM for human DHODH. Brequinar has potent activities against a broad spectrum of viruses.
More Information
Supplier Page
CSNpharm
Brequinar (DUP785) is a potent inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of 5.2 nM for human DHODH. Brequinar has potent activities against a broad spectrum of viruses.
More Information
Supplier Page
CSNpharm
Brequinar (DUP785) is a potent inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of 5.2 nM for human DHODH. Brequinar has potent activities against a broad spectrum of viruses.
More Information
Supplier Page
CSNpharm
Brequinar (DUP785) is a potent inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of 5.2 nM for human DHODH. Brequinar has potent activities against a broad spectrum of viruses.
More Information
Supplier Page
CSNpharm
Brequinar (DUP785) is a potent inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of 5.2 nM for human DHODH. Brequinar has potent activities against a broad spectrum of viruses.
More Information
Supplier Page
CSNpharm
Biphenquinate is Dihydroorotate Dehydrogenase (DHODH) inhibitor with an IC50 value of ∼20nM. It triggers differentiation in ER-HoxA9, U937, and THP1 cells at an EC50 of < 1 μM.
More Information
Supplier Page
CSNpharm
Biphenquinate is Dihydroorotate Dehydrogenase (DHODH) inhibitor with an IC50 value of ∼20nM. It triggers differentiation in ER-HoxA9, U937, and THP1 cells at an EC50 of < 1 μM.
More Information
Supplier Page
CSNpharm
Biphenquinate is Dihydroorotate Dehydrogenase (DHODH) inhibitor with an IC50 value of ∼20nM. It triggers differentiation in ER-HoxA9, U937, and THP1 cells at an EC50 of < 1 μM.
More Information
Supplier Page
CSNpharm
Biphenquinate is Dihydroorotate Dehydrogenase (DHODH) inhibitor with an IC50 value of ∼20nM. It triggers differentiation in ER-HoxA9, U937, and THP1 cells at an EC50 of < 1 μM.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Brevianamide F is an alkaloid metabolite produced by various Streptomyces, Actinomycetes, and Aspergillus strains with antibacterial effect on M. luteus and S. aureus and Bacille Calmette-Guerin M. bovis strain.
More Information
Supplier Page
CSNpharm
Brevianamide F is an alkaloid metabolite produced by various Streptomyces, Actinomycetes, and Aspergillus strains with antibacterial effect on M. luteus and S. aureus and Bacille Calmette-Guerin M. bovis strain.
More Information
Supplier Page
CSNpharm
Brevianamide F is an alkaloid metabolite produced by various Streptomyces, Actinomycetes, and Aspergillus strains with antibacterial effect on M. luteus and S. aureus and Bacille Calmette-Guerin M. bovis strain.
More Information
Supplier Page
CSNpharm
Brevianamide F is an alkaloid metabolite produced by various Streptomyces, Actinomycetes, and Aspergillus strains with antibacterial effect on M. luteus and S. aureus and Bacille Calmette-Guerin M. bovis strain.
More Information
Supplier Page
CSNpharm
Brevilin A, a natural product isolated and purified from the herbs of Centipeda minima, is a strong impetus for the development of selective JAK-STAT inhibitors and therapeutic drugs in order to improve survival of patients with hyperactivated JAKs and STATs, and has antigiardial activity (IC50 = 16.1 μM) and was similarly active in vitro against […]
More Information
Supplier Page
CSNpharm
Brevilin A, a natural product isolated and purified from the herbs of Centipeda minima, is a strong impetus for the development of selective JAK-STAT inhibitors and therapeutic drugs in order to improve survival of patients with hyperactivated JAKs and STATs, and has antigiardial activity (IC50 = 16.1 μM) and was similarly active in vitro against […]
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Brimonidine tartrate is an α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, used to treat glaucoma through a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.
More Information
Supplier Page
CSNpharm
Brimonidine tartrate is an α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, used to treat glaucoma through a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.
More Information
Supplier Page
CSNpharm
Brimonidine tartrate is an α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, used to treat glaucoma through a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Brivudine is an antiviral drug acts by inhibiting replication of the target virus, used in the treatment of Herpes Zoster.
More Information
Supplier Page
CSNpharm
Brivudine is an antiviral drug acts by inhibiting replication of the target virus, used in the treatment of Herpes Zoster.
More Information
Supplier Page
CSNpharm
Brivudine is an antiviral drug acts by inhibiting replication of the target virus, used in the treatment of Herpes Zoster.
More Information
Supplier Page
CSNpharm
Brivudine is an antiviral drug acts by inhibiting replication of the target virus, used in the treatment of Herpes Zoster.
More Information
Supplier Page
CSNpharm
BRL-52537 hydrochloride is a potent and highly selective κ-opioid agonist. It has neuroprotective effects in animal studies, and is used for research into potential treatments for stroke and heart attack as well as more general brain research.
More Information
Supplier Page
CSNpharm
BRL-52537 hydrochloride is a potent and highly selective κ-opioid agonist. It has neuroprotective effects in animal studies, and is used for research into potential treatments for stroke and heart attack as well as more general brain research.
More Information
Supplier Page
CSNpharm
BRL-52537 hydrochloride is a potent and highly selective κ-opioid agonist. It has neuroprotective effects in animal studies, and is used for research into potential treatments for stroke and heart attack as well as more general brain research.
More Information
Supplier Page
CSNpharm
BRL-52537 hydrochloride is a potent and highly selective κ-opioid agonist. It has neuroprotective effects in animal studies, and is used for research into potential treatments for stroke and heart attack as well as more general brain research.
More Information
Supplier Page
CSNpharm
BRL-52537 hydrochloride is a potent and highly selective κ-opioid agonist. It has neuroprotective effects in animal studies, and is used for research into potential treatments for stroke and heart attack as well as more general brain research.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
BRL-15572 2HCl is a selective h5-HT1D antagonist, displaying 60-fold selectivity over h5-HT1B and exhibiting little or no affinity for a range of other receptor types.
More Information
Supplier Page
CSNpharm
BRL-15572 2HCl is a selective h5-HT1D antagonist, displaying 60-fold selectivity over h5-HT1B and exhibiting little or no affinity for a range of other receptor types.
More Information
Supplier Page
CSNpharm
BRL-15572 2HCl is a selective h5-HT1D antagonist, displaying 60-fold selectivity over h5-HT1B and exhibiting little or no affinity for a range of other receptor types.
More Information
Supplier Page
CSNpharm
Bromfenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID), which has anti-inflammatory activity and may block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2.
More Information
Supplier Page
